Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

Cell Death and Disease
July 13, 2022
Cited by 64


Related Papers

No related papers found

Powered by citation graph analysis